Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBOFLAVIN 5^-PHOSPHATE vs RIFAMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBOFLAVIN 5^-PHOSPHATE vs RIFAMYCIN: Safety Overview

Metric	RIBOFLAVIN 5^-PHOSPHATE	RIFAMYCIN
Total FAERS Reports	244	106
Deaths Reported	9	26
Death Rate	3.7%	24.5%
Hospitalizations	13	35
Average Patient Age	34.8 yrs	56.1 yrs
% Female Patients	39.6%	54.5%
FDA Approval Date	N/A	Nov 16, 2018
Marketing Status	N/A	Discontinued